A Cleveland Clinic analysis of nearly 8,000 patients found that discontinuing semaglutide and tirzepatide did not lead to significant immediate weight regain in clinical practice
In previous large-scale clinical trials of GLP-1RAs, 15.2% ( n = 618) of AMPLITUDE-O and 6.1% ( n = 575) of Harmony Outcomes patients used SGLT2is at baseline [18, 20] (Table 1)
Geneva, Switzerland: World Health Organization (2024)
Gradually, your doctor will increase your dose to minimize the risk of side effects from the new medication
Clinics often include these treatments into broader wellness services that target skin health, metabolic recovery, and detox support
Combat chronic fatigue, pain, & migraines